390 results on '"G. Frank"'
Search Results
2. Handling Missing Data in Clinical Trials with Bayesian and Frequentist Approaches
3. ‘I Said: Hymn 38!’ The Reception of the Protestant Reformation in The Netherlands at the Turn of the Millennium—The Case of ‘The White Cowboy’
4. Certification of Civil Avionics
5. The Local Lymph Node Assay
6. Utilization of Peptide Reactivity Assays for the Prediction of Skin Sensitization
7. Applications of Simulation for Missing Data Issues in Longitudinal Clinical Trials
8. Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert system
9. Predictors of perforation during lead extraction: Results of the Canadian Lead ExtrAction Risk (CLEAR) study
10. AllerCatPro 2.0: a web server for predicting protein allergenicity potential
11. Benchmarking performance of SENS-IS assay against weight of evidence skin sensitization potency categories
12. Susceptibility to Irritation in the Elderly
13. Weight of Evidence Approach for Skin Sensitization Potency Categorization of Fragrance Ingredients
14. Implementation of a dermal sensitization threshold (DST) concept for risk assessment: structure-based DST and in vitro data-based DST
15. An Application of Bayesian Approach for Testing Non-inferiority Case Studies in Vaccine Trials
16. Susceptibility to Irritation in the Elderly
17. The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota l-carnitine catabolism
18. Handling Intercurrent Events Through Hypothetical Strategy in Delayed-Start Designs
19. Identifying a reference list of respiratory sensitizers for the evaluation of novel approaches to study respiratory sensitization
20. Bayesian Approaches for Handling Hypothetical Estimands in Longitudinal Clinical Trials With Gaussian Outcomes
21. Critical Evaluation of Low-Molecular Weight Respiratory Sensitizers and Their Protein Reactivity Potential Toward Lysine Residues
22. On Analysis of Low Incidence Adverse Events in Clinical Trials
23. The local lymph node assay
24. Bayesian Sensitivity Analysis in Survival and Longitudinal Trials with Missing Data
25. Immunotoxicology Testing: Past and Future
26. Application of the dermal sensitization threshold concept to chemicals classified as high potency category for skin sensitization assessment of ingredients for consumer products
27. Refinement of the Peroxidase Peptide Reactivity Assay and Prediction Model for Assessing Skin Sensitization Potential
28. Dynamic RMST curves for survival analysis in clinical trials
29. Dynamic RMST Curves for Survival Analysis in Clinical Trials
30. Determination of the relative allergenic potency of proteins: hurdles and opportunities
31. Dynamic RMST Curves for Survival Analysis in Clinical Trials
32. Dynamic RMST Curves for Survival Analysis in Clinical Trials
33. Model Averaging Using Likelihoods That Reflect Poor Outcomes for Clinical Trial Dropouts
34. Risk Assessment of Sensitizing Agents
35. A review of substances found positive in 1 of 3 in vitro tests for skin sensitization
36. Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine
37. Proteomic and Bioinformatic Analyses for the Identification of Proteins With Low Allergenic Potential for Hazard Assessment
38. AllerCatPro—prediction of protein allergenicity potential from the protein sequence
39. Investigating Contact Photoallergy in the Mouse
40. Effects of Human Activities and Sea Level Rise on Wetland Ecosystems in the Cape Fear River Estuary, North Carolina, USA
41. Heroin history
42. Obituary
43. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint
44. Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine
45. Control-Based Imputation and Delta-Adjustment Stress Test for Missing Data Analysis in Longitudinal Clinical Trials
46. Quantitative risk assessment for skin sensitization: Success or failure?
47. A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months
48. Heterogeneity of Rotavirus Vaccine Efficacy Among Infants in Developing Countries
49. The Use of Peptide Reactivity Assays for Skin Sensitisation Hazard Identification and Risk Assessment
50. Classification and Surgical Repair of Injuries Sustained During Transvenous Lead Extraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.